-
1.
公开(公告)号:US11085929B2
公开(公告)日:2021-08-10
申请号:US16119100
申请日:2018-08-31
IPC: G01N33/68 , C01G23/053 , C01G23/08
Abstract: Certain embodiments of the invention provide TiO2 nanoshell particles, methods of fabricating TiO2 nanoshell particles, and methods of enriching peptides in a sample using TiO2 nanoshell particles.
-
公开(公告)号:US20230314427A1
公开(公告)日:2023-10-05
申请号:US17617802
申请日:2020-06-15
Inventor: Ye Hu , Xiangxing Kong , Tanxi Cai , Qingbo Shu
IPC: G01N33/569 , G01N33/68 , G01N33/543
CPC classification number: G01N33/569 , G01N33/6848 , G01N33/54326 , G01N2458/15 , G01N2446/00 , G01N2333/35
Abstract: Provided herein are methods for detecting and identifying disease-specific biomarkers, such as target antigens associated with infection.
-
公开(公告)号:US12072479B2
公开(公告)日:2024-08-27
申请号:US18069572
申请日:2022-12-21
CPC classification number: G02B21/0008 , G01N21/51 , G01N33/587 , G02B21/025 , G02B21/10 , G02B21/26 , G01N2201/0221
Abstract: A mobile phone-based dark field microscope (MDFM) apparatus suitable for quantifying nanoparticle signals is provided. The MDFM apparatus includes an electrically operated light source, a dark-field condenser, a slide housing configured to receive an analytical slide, and an adapter housing configured to receive an objective lens and receive a portable electronic communication device. The slide housing positions the analytical slide between the objective lens and the dark-field condenser. The adapter housing registers the objective lens with a camera lens of the portable electronic communication device. A method for performing a biological quantitative study using the dark-field microscope apparatus is further provided.
-
公开(公告)号:US20190234952A1
公开(公告)日:2019-08-01
申请号:US16211040
申请日:2018-12-05
Inventor: Ye Hu
IPC: G01N33/574 , G01N33/68
CPC classification number: G01N33/57438 , G01N33/6848
Abstract: In certain embodiments, the present invention provides a method of detecting hypoxia status in a tumor cell by detecting a level of hydroxyprolyl BK (Hyp-BK) peptides in a patient sample, and detecting a level of bradykinin (BK) peptides the patient sample, wherein a change in the Hyp-BK/BK ratio as compared to the Hyp-BK/BK ratio in a comparable normal cell is a marker for tumor hypoxia.
-
5.
公开(公告)号:US20190064178A1
公开(公告)日:2019-02-28
申请号:US16119100
申请日:2018-08-31
IPC: G01N33/68 , C01G23/053 , C01G23/08
Abstract: Certain embodiments of the invention provide TiO2 nanoshell particles, methods of fabricating TiO2 nanoshell particles, and methods of enriching peptides in a sample using TiO2 nanoshell particles.
-
-
-
-